Studies involving pancreatic cancer PDX mice showed that LY2090314, a specific small-molecule GSK-3β inhibitor, led to a reduction in TAK1 and YAP/TAZ protein levels and a consequent decrease in cell proliferation [32]. The gene discussed is GSK3B; the disease is pancreatic neoplasm.